Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gries

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|August 26, 2000
Linear mixed-effect multivariate adaptive regression splines applied to nonlinear pharmacokinetics dataJ M Gries, D Verotta
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systemsJ M Gries, N Benowitz, D Verotta
Clinical Pharmacology and Therapeutics|October 1, 1996
Chronopharmacokinetics of nicotineJ M Gries, N Benowitz, D Verotta
Journal of Pharmaceutical Sciences|April 1, 1996
A descriptive tool to characterize nonlinear kinetics, with applications to meperidine and lidocaineJ M Gries, R Upton, Y F Huang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropinJ M Gries, A Munafo, H C Porchet, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complexJ M Gries, I F Troconiz, D Verotta, et al.
Therapie|May 1, 1994
[Relationship between hepatic cytochrome P-450 3A and acute cyclosporine toxicity in liver transplantation]A Lemoine, D Azoulay, L Kiffel, et al.
Transplantation Proceedings|June 1, 1993
Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipientD Azoulay, A Lemoine, J M Gries, et al.
Hepatology (Baltimore, Md.)|June 1, 1993
Incidence of adverse reactions to cyclosporine after liver transplantation is predicted by the first blood levelD Azoulay, A Lemoine, A Dennison, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|August 26, 2000
Linear mixed-effect multivariate adaptive regression splines applied to nonlinear pharmacokinetics dataJ M Gries, D Verotta
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systemsJ M Gries, N Benowitz, D Verotta
Clinical Pharmacology and Therapeutics|October 1, 1996
Chronopharmacokinetics of nicotineJ M Gries, N Benowitz, D Verotta
Journal of Pharmaceutical Sciences|April 1, 1996
A descriptive tool to characterize nonlinear kinetics, with applications to meperidine and lidocaineJ M Gries, R Upton, Y F Huang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropinJ M Gries, A Munafo, H C Porchet, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complexJ M Gries, I F Troconiz, D Verotta, et al.
Therapie|May 1, 1994
[Relationship between hepatic cytochrome P-450 3A and acute cyclosporine toxicity in liver transplantation]A Lemoine, D Azoulay, L Kiffel, et al.
Transplantation Proceedings|June 1, 1993
Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipientD Azoulay, A Lemoine, J M Gries, et al.
Hepatology (Baltimore, Md.)|June 1, 1993
Incidence of adverse reactions to cyclosporine after liver transplantation is predicted by the first blood levelD Azoulay, A Lemoine, A Dennison, et al.
Pageof 2